MTOR and chronic myelogenous leukemia, BCR-ABL1 positive: UA has been shown to induce apoptosis and antimetastatic activity by destructing the PI3K/Akt/mTOR signaling pathways in human chronic myelogenous leukemia and breast cancer [35,36].